Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Morning Alexa Flash Briefings of April 28th
Morning Alexa Flash Briefings
Key Inflation Gauge Tracked by the Fed Remained High in March
A key index of underlying inflation that is closely followed by the Federal Reserve remained elevated last month, keeping the Fed on track to raise interest rates next week for the 10th time since March of last year.
Powerful New Obesity Drug Poised to Upend Weight Loss Care
As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
Mastercard Posts Strong Q1 on Travel Spending
Mastercard posted strong quarterly results, helped by a rebound in travel drove growth.
Judge Cracks Down on Elon Musk's Autopilot Statements
A California judge is ordering Tesla CEO Elon Musk to be interviewed under oath regarding statements about the safety and capability of the car maker's autopilot features.
Analyst Breaks Down Thursday's Market as Stocks Climb Amid Strong Tech Earnings
David Wright, president and owner of Wright Financial Group LLC, joined Cheddar News to discuss Thursday's trading as stocks closed higher amid strong tech profits. But Wright says banking stress could sway markets down as the Federal Reserve could weigh more rate increases.
Lyft Laying Off Over 1,000 Workers
Lyft announced it's laying off over 1,000 workers, or about 26% of its workforce, and also revealed it's scaling back hiring.
Gap Cuts 1,800 Corporate Jobs Amid Sales Slump
The Gap is laying off 1,800 corporate workers, roughly three time the number of headquarters jobs it cut last fall, as the struggling chain cuts costs in a bid to become more nimble.
Cheddar Afternoon News Briefings of April 27th
Cheddar Afternoon News Briefings
